Latest filing published 27 Sept 2012 for Aevi Genomic Medicine, LLC, €43k.
Insider track record
No signal scores available.
Phyllis K. Bellin: trading record in brief
Phyllis K. Bellin discloses dealings in Aevi Genomic Medicine, LLC to SEC (Form 4). We count 4 filings; the first trade dates from 11 September 2012 and the latest from 21 September 2012.
Sales make up the whole of the open-market record (2 sales, €46k). Outside the open market, there are 1 share grant and 1 option exercise.
The record was last updated on 27 September 2012 with an open-market sale (€43k) in Aevi Genomic Medicine, LLC. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Phyllis K. Bellin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,082 shares@ US$10.92Common StockSEC:0001144204-12-053220:0
- 400 shares@ US$10.90Common StockSEC:0001144204-12-053220:1
- 13,964 shares@ US$7.35Common StockSEC:0001144204-12-051186:0
- 8,482 shares@ US$12.10Common StockSEC:0001144204-12-051186:1
4 of 4 declarations